RenovoRx, Inc. (RNXT)
1.15
-0.10
(-8.00%)
USD |
NASDAQ |
Oct 13, 16:00
1.14
-0.01
(-0.87%)
After-Hours: 20:00
RenovoRx EPS Diluted (TTM) : -0.314 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.314 |
| March 31, 2026 | -0.3316 |
| December 31, 2025 | -0.3161 |
| September 30, 2025 | -0.3555 |
| June 30, 2025 | -0.3751 |
| March 31, 2025 | -0.3952 |
| December 31, 2024 | -0.3901 |
| September 30, 2024 | -0.5722 |
| June 30, 2024 | -0.606 |
| March 31, 2024 | -0.7251 |
| December 31, 2023 | -1.011 |
| September 30, 2023 | -0.9466 |
| June 30, 2023 | -1.049 |
| Date | Value |
|---|---|
| March 31, 2023 | -1.117 |
| December 31, 2022 | -1.093 |
| September 30, 2022 | -1.120 |
| June 30, 2022 | -1.054 |
| March 31, 2022 | -0.9184 |
| December 31, 2021 | -0.7169 |
| September 30, 2021 | -0.5763 |
| June 30, 2021 | -0.4959 |
| March 31, 2021 | -0.466 |
| September 30, 2020 | -0.3335 |
| June 30, 2020 | -0.2105 |
| March 31, 2020 | -0.1213 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Enanta Pharmaceuticals, Inc. | -2.411 |
| Travere Therapeutics, Inc. | -0.7636 |
| REGENXBIO, Inc. | -3.785 |
| Krystal Biotech, Inc. | 7.979 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |